InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Molineaux Christopher P., Director. Officer active across 1 company, notably Aclaris Therapeutics, Inc.. Cumulatively, 6 reports have been published. Activity tracked since 15 June 2023. The latest transaction was disclosed on 20 June 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
6 of 6 declarations
Christopher P. Molineaux is a Board Member at Aclaris Therapeutics, Inc., a biopharmaceutical company focused on developing dermatological treatments. As a board member, he participates in overseeing the company's strategies and making key decisions. Christopher brings expertise in biopharmacy and product development.